The evidence from epidemiological studies, studies of biochemical markers of exposure and toxicological studies, con®rm that there is a causal association between the risk of lung cancer and exposure to environmental tobacco smoke. Nonsmokers can inhale and metabolize carcinogens in tobacco smoke and other markers of environmental tobacco smoke inhalation (nicotine and cotinine) are raised in nonsmokers exposed to environmental tobacco smoke. In epidemiological studies of women who are lifelong nonsmokers, there is a statistically signi®cant excess risk of lung cancer (24%, 95% con®dence interval 13±36%) from exposure to environmental tobacco smoke from the spouse and this increases with the number of cigarettes smoked and duration of marriage. Misclassi®cation bias (women who smoke but claim to be lifelong nonsmokers) and dietary confounding are unlikely to explain the association; after adjustment for both, the risk of lung cancer from environmental tobacco smoke exposure was still statistically signi®cant. In any event, their effects on the risk of lung cancer in the epidemiological studies are balanced out by allowing for background exposure to environmental tobacco smoke (that is, other than from the spouse) in the reference group; the excess risk after allowing for all three is an estimated 26% (95% con®dence interval 7±47%), similar to the unadjusted ®gure of 24%. In Britain, about one in every six nonsmokers are exposed to tobacco smoke from smokers in the home. Passive smoking is an avoidable cause of mortality and morbidity. Prevention strategies to reduce the amount of cigarette smoking in public places should be part of public health policy.
Introduction
The hazardous health effects of active smoking have been well documented throughout the years. Attention later focused on the effects on the nonsmoker exposed to tobacco smoke. Two reports from the United States Surgeon General on smoking and health, published in 1975 1 and 1979, 2 were amongst the ®rst of®cial scienti®c reports to address the issue of exposure to environmental tobacco smoke, also referred to as`involuntary smoking' or`passive smoking'. The reports, whilst not establishing a causal link with diseases such as cancer or heart disease, concluded that passive smoking was a health concern and that research was needed to quantify the effects. Two years later, in 1981, the ®rst three epidemiological studies 3±5 were published which assessed the effect of passive smoking on the risk of lung cancer in nonsmoking women with husbands who smoked. One was a large cohort study from Japan 3 and another was a case-control study from Greece, 4 both reported a statistically signi®cant increased risk of lung cancer. The third study was a cohort study from the American Cancer Society 5 in which the author concluded that there was little or no excess risk associated with exposure to tobacco smoke, as although an increased risk was found it was not statistically signi®cant.
Epidemiological studies subsequently accumulated and it was not until about 10 years ago when several of®cial scienti®c bodies 6±9 concluded that exposure to environmental tobacco smoke is a cause of lung cancer in lifelong nonsmokers. In 1992, the United States Environmental Protection Agency 10 classi®ed environmental tobacco smoke as a class A human lung carcinogen. As a consequence, the public have become more aware of the adverse health effects and smoking has been banned in an increasing number of public places, both at work and in social settings. Yet, despite the scienti®c conclusions, some still argue that the association is not causal and the excess risk observed in epidemiological studies can be explained by bias or confounding or both. 11±13 It is plausible that exposure to environmental tobacco smoke (ETS) causes lung cancer. The causal association between lung cancer and active smoking is well established, as is the dose±response relationship. Tobacco smoke in ambient air, most of which is un®ltered smoke from the burning end of the cigarette, contains the same toxic agents breathed in by active smokers, albeit to a lesser extent. Passive smoking is, therefore, not a separate entity to active smoking. Passive smoking is a form of low dose active smoking and, in the absence of a dose±response threshold, is expected to convey some risk.
The evidence for a causal association is not restricted to epidemiological studies, in which a direct estimate of the excess risk can be obtained. There is evidence on biochemical markers of tobacco smoke exposure in passive smokers (namely, cotinine and nicotine) which, when compared to that in active smokers, allows extrapolation from the risk in active smokers. There are also several toxicological studies of measurements of carcinogens in passive smokers.
This article is based on results from a review of the evidence published elsewhere. 14 
Epidemiological studies
Since 1981, when the ®rst epidemiological studies reported on the association between lung cancer and passive smoking, there have been over 50 published studies. Individuals with and without lung cancer were selected if they were lifelong nonsmokers and information obtained on their exposure to ETS. Various measures of exposure have been used, of which exposure from the spouse (or cohabitant) is the most common. It is probably the best available measure because it is both well de®ned and it has been validated since studies have shown that cotinine levels are raised in nonsmokers who live with smokers. 15±18 Exposures such as at the workplace or in social settings have been less well validated and are more dif®cult to quantify as they vary considerably between different environments. Exposure during childhood has not been validated and even if it were, no study has reported results strati®ed by exposure from the spouse. Spousal exposure is a marker of tobacco smoke exposure in general, as people who live with smokers are more likely to mix with smokers outside the home. 15, 17 Estimates of risk from epidemiological studies which have used this measure, therefore, re¯ect exposure in the general population.
There are 39 published studies which report on the risk of lung cancer in lifelong nonsmokers according to the smoking status of the spouse (or cohabitant), excluding updated or duplicate reports and those in which an estimate of risk (and its standard error) could not be calculated as there were too few cases. Most used women as subjects as it is easier to identify nonsmoking women with a smoking husband than nonsmoking men with a smoking wife. For simplicity, as there are in total only 274 male lung cancer cases, the focus of attention here will be on the 37 studies of women (91% of all lung cancer cases). 5,19±54 In any case, the pooled estimate from studies of men is consistent with that from studies of females. Of the 37 studies of nonsmoking women, ®ve are cohort studies and 34 are case-control studies; collectively they represent 4626 cases of lung cancer (Table 1 ). In the case-control studies, controls were selected from either the general population or patients with nonsmoking-related diseases. Age was generally similar in cases and controls, if they were not speci®cally age-matched.
In the case-control studies, the relative risk of lung cancer due to smoking from the spouse was estimated from the odds ratio, for example, the following is the data from Geng et al. (1988) . 38 Husband is a:
Smoker
Nonsmoker Lung cancer cases 34 50
Controls

73
The odds ratio is 2.16 [(34 Â 73)/(66 Â 50)], with variance (of the log odds ratio) 1/34 + 1/50 + 1/66 + 1/73. Some studies also gave odds ratios adjusted for factors such as social class, occupation and diet, but as these were similar to the unadjusted ones and different studies adjusted for different factors, the unadjusted estimates were used in the analysis. Where age was not similar in cases and controls or only adjusted estimates were available, the age-adjusted odds ratios were used. 29, 47, 53 In the cohort studies, the published age-adjusted relative risks were used to allow for differences in age. Figure 1 shows the individual estimates of the relative risk of lung cancer in nonsmoking women with spouses who smoke compared to those who do not, ordered according to the size of the estimate, with the size of the standard error indicated. Most case-control studies found a raised relative risk, as did all four cohort studies, which included the two large studies from the American Cancer Society. There is little evidence of publication bias since seven studies found a statistically signi®cant relative risk, all of which were raised. If these were due to chance, there would be an estimated 241 unpublished studies, 55 which is so impossible as to be ruled out. Furthermore, given the controversial nature of the subject, it is unlikely that there would have been many studies with negative results that were not published. 56 The pooled relative risk from the 37 studies of nonsmoking women is highly statistically signi®cant (p`0.001); 1.21 (95% CI 1.12±1.30) using the ®xed effects approach and 1.24 (95% CI 1.13±1.36) using the random effects approach. 57 The estimate is consistent with that obtained from previous reviews. Figure 2 is a cumulative plot of the pooled relative risk of lung cancer over time. Even from as early as 1984, the estimate of risk has not materially changed despite the accumulation of many studies. Further studies are unlikely to greatly in¯uence the present summary estimate.
Is there evidence of heterogeneity?
Since the epidemiological studies had different study designs, came from different countries and were published over several years, it is possible that there is heterogeneity in the risk estimates and so a pooled estimate from all studies would not be a valid measure of the risk. Sources of heterogeneity were identi®ed using a chi-squared test 57 and a general linear model of the relative risk (in logarithms, weighted by the inverse of the square of its standard error). Table 2 shows the pooled estimates of risk according to geographical location, publication year, study design and the number of lung cancer cases. There was no indication that the estimates differed signi®cantly between geographical location (p = 0.25) or within USA, Europe and Japan (p b 0.49); there was only evidence of heterogeneity for studies within China and Hong Kong. This was, however, due to the study by Wu-Williams et al. (1990) . 43 Similarly, the estimates of risk did not differ between publication year, study type or size of study in relation to number of lung cancers; there was heterogeneity only when this study was included. This was a relatively large study from north-east China (417 lung cancers) and it had a relative risk of 0.79 (95% CI 0.62±1.02) which suggested that exposure to ETS from the spouse had an implausible protective effect. In this study, there were more potent causes of lung cancer, namely exposure to other air pollutants such as cooking and heating fuels and it is likely that this obscured the effect of exposure to ETS, as suggested by the authors. Since the result was not statistically signi®cant, chance could have made the risk estimate below one.
The overall test for heterogeneity when applied to all 37 studies was not signi®cant (p = 0.10). When the study from China was excluded, there was even less evidence of heterogeneity (p = 0.46); the pooled relative risk was 1.26 (95% CI 1.16±1.36) using both the ®xed and random effects approach. It is useful to observe that despite having as many as 37 studies from several countries and during a 17-year time period (1981±97) there are no major sources of variation and the results of the studies consistently showed an increased risk. The pooled estimate is, therefore, a valid estimate of the risk of lung cancer due to exposure to ETS.
Is there evidence of a dose±response relationship with risk?
Biochemical studies of serum and urinary cotinine (a marker of exposure to tobacco smoke) in nonsmokers living with smokers have found a signi®cant trend between cotinine concentrations and the number of cigarettes smoked by the spouse. 16, 58, 59 It is expected, therefore, that there would be a trend with the risk of lung cancer.
With the accumulation of epidemiological studies, several have also reported on the risk of lung cancer in nonsmoking women according to the extent of exposure from the spouse, in particular his daily cigarette consumption and the number of years they have been living together. It is, therefore, possible to assess whether a dose±response relationship exists between the risk of lung cancer and level of exposure to ETS.
In the epidemiological studies, data on the cigarette consumption of the spouse were presented according to speci®ed intervals, for example, 0, 1±10, 11±20 and 21+ cigarettes per day, where zero indicates a nonsmoking spouse. For most studies, the number of cases and controls were given in each group whereas for the others only the relative risk and its con®dence interval were given in each exposure interval. Similarly, for the number of years of marriage.
For each study, where possible, a chi-squared test to assess departure from a linear trend was performed for cigarette consumption and duration of marriage; none were signi®cant, indicating that a linear trend in risk can be assumed. A weighted regression analysis was then performed in each study between the relative risk (in logarithms, weighted by the inverse of the square of its standard error) and the midpoint of each exposure interval to give an estimate of the slope. 60 To allow for the possibility of obtaining a spurious trend by including the unexposed group (that is, the reference group with relative risk 1.0), regression analyses were performed with and without an intercept term. The estimates of the slope were then pooled. 60 Table 3 shows the results of the dose±response analysis expressed as the percentage increase in risk for 10 cigarettes smoked daily by the spouse or 10 years of marriage to a smoker. The pooled estimates were statistically signi®cant for both cigarette consumption and the number of years the woman lived with a spouse who smoked. The estimates were similar if the unexposed group were excluded.
Although the estimates of risk are useful, it is the presence of the dose±response relationships that are important as they strengthen the evidence of a cause and effect association between ETS exposure and the risk of lung cancer.
Can bias and dietary confounding explain the association?
A potential source of bias and a source of confounding have been suggested to explain most or all of the excess risk of lung cancer in the epidemiological studies. 11±14 The bias, usually referred to as misclassi®cation bias, is due to some women in the epidemiological studies who claim to be lifelong nonsmokers but are, in fact, current or former smokers. The bias arises from the observation that a woman who smokes is more likely to live with a spouse who also smokes than one who does not. Since she has a higher risk of lung cancer (because of her smoking status) this would tend to in¯ate the excess risk from exposure to ETS from the spouse. 32 22 À24 Humble 34 15 À18 23 11 Lam 35 44 À2 Gao 36 4 À3 Geng 38 55 40 The magnitude of the bias will depend on the prevalence of women who smoke or are former smokers, the extent to which these women are misclassi®ed as lifelong nonsmokers, their risk of lung cancer and the extent to which these women live with a smoker. The higher the prevalence of current and former smokers the more likely they are to be included in epidemiological studies. The prevalence of smoking in women will vary from study to study, for example, in Britain it is about 50% compared to about 10% or less in some parts of China. The proportion of these women who claim to be lifelong nonsmokers is about 7% in Britain. 14 Since these women smoke, or used to smoke, their risk of lung cancer will be higher than true lifelong nonsmokers. However, misclassi®ed current smokers tend to be light smokers and misclassi®ed former smokers had usually given up for several years, so the average relative risk is about 3 in these women. 14 The extent to which smokers live with smokers has been quanti®ed in several studies, 14 in Britain, a woman who smokes is, on average, three times more likely to have a spouse who also smokes than one who does not. 14 The magnitude of the bias increases with increasing values of any of these factors. It does, however, require implausibly large values of the factors to explain the excess risk of lung cancer from exposure to ETS from the spouse (relative risk 1.24, 95% CI 1.13± 1.36), that is, to give a result that is not statistically signi®cant. 14 The estimated relative risk after allowing for misclassi®cation bias and using the best available estimates of the factors is 1.18 (95% CI 1.06±1.30); a result that is still statistically signi®cant. 14 Dietary differences between nonsmoking women, with and without a spouse who smokes, is a possible source of confounding. A low consumption of fruits and vegetables may be associated with an increased risk of lung cancer and since nonsmokers living with smokers are likely to have similar diets and smokers eat less fruits and vegetables than nonsmokers, it is possible that this may account for some or all of the excess risk observed in the epidemiological studies.
The extent of dietary confounding will depend on two factors, the difference in fruit and vegetable consumption between women who live with a smoker and those who do not, and the risk of lung cancer in nonsmokers according to the consumption of these foods. The observed difference in dietary intake is not great, however, and the intake of fruits and vegetables in about 55% of nonsmokers living with smokers is less than the mean intake for unexposed nonsmokers (corresponding to an average difference in intake of À0.12 standard deviations). 14 The estimated excess risk of lung cancer associated with fruit and vegetable consumption is 50% (relative risk 1.50) for nonsmokers in the lowest quartile of consumption compared to those in the highest quartile (this corresponds to a relative risk of 1.20 for a decrease in consumption of one standard deviation). Using these estimates, the observed relative risk of lung cancer reduces from 1.24 to 1.21 (95% CI 1.11±1.33); 14 where 1.02 is the risk associated with diet in passive smokers (exp[(log e 1.20)Â0.12]) and so the relative risk due to passive smoking after allowing for dietary confounding is 1.24/1.02=1.21. The effect of dietary confounding is small. This is in agreement with the results of the eight epidemiological studies which assessed the effect of diet on the risk of lung cancer in women exposed to ETS from the spouse, where they all found the effect of dietary confounding to be negligible.
Even after allowing for the effects of both misclassi®cation bias and dietary confounding, the risk due to exposure to ETS remains statistically signi®cant with a relative risk of 1.16 (95% CI 1.04±1.27).
Underestimation of risk by using exposure from the spouse as a marker of environmental tobacco smoke exposure
Whilst exposure to ETS from the spouse is a good marker of ETS exposure in epidemiological studies, it is limited by the fact that some nonsmoking women in the unexposed group, that is those who are assumed to have zero risk, will be exposed to ETS from people other than the spouse, both inside and outside the home. 14 These women will, therefore, have some risk of lung cancer and the effect of this is to dilute the true risk from exposure to ETS in general (Figure 3 ). This observation is con®rmed in studies which have showed that nonsmokers living with nonsmokers do not have zero levels of cotinine in their urine, 15±18 yet tobacco smoke is practically the only source of cotinine. The effect on the estimate of risk will be greatest in those populations in which contact with smokers is common. In Japan, for example, where the prevalence of smoking in men is high (70%), a study showed that nonsmokers living with nonsmokers had urinary cotinine concentrations about 6% of that in active smokers, 58 whereas it is considerably less than 1% in some Western countries.
The excess risk of lung cancer in nonsmokers living with nonsmokers who are exposed from other sources compared to those with no exposure at all, can be estimated from studies which have measured cotinine in nonsmokers. Urinary cotinine concentrations are, on average, three times higher in nonsmokers living with smokers than those who live with nonsmokers. 15±18 Accordingly, if x is the estimated excess risk of lung cancer in nonsmokers living with nonsmokers, then 3x is the excess risk in those living with smokers. An estimate of x is thus obtained from the observed relative risk from the epidemiological studies (Table 1 ) using the following expression: observed relative risk: 1X24 1 3xa1 x Figure 3 Illustration of how exposure to ETS from the spouse as a marker of general exposure can dilute the relative risk of lung cancer in the epidemiological studies, given that some nonsmokers living with a nonsmoking spouse will be exposed to ETS outside the home The estimate of x is 14% (relative risk 1.14) and 3x is thus 42%. After allowing for ETS exposure in the unexposed group in the epidemiological studies, the relative risk in nonsmokers with a spouse who smokes increases from 1.24 to 1.42 (95% CI 1.21± 1.66). 14 Although this is clearly not a negligible effect it is often not addressed in reviews of lung cancer and exposure to ETS.
The effect of background exposure to ETS tends to cancel out the in¯ationary effects of misclassi®cation bias and dietary confounding. The estimated relative risk from ETS exposure after allowing for all three effects is 1.26 (95% CI 1.06±1.47). 14 This estimate is close to the unadjusted one obtained directly from the epidemiological studies (relative risk 1.24, Table 1 ). It is, therefore, useful to know that the observed estimates can be used as a valid measure of the risk of lung cancer associated with passive smoking.
Nicotine and cotinine as biochemical markers of tobacco smoke exposure
Nicotine, and its metabolite cotinine, have long been used as measures of tobacco smoke intake. Nicotine is absorbed into the bloodstream and metabolizes into cotinine and both are excreted in the urine. They are practically tobacco-speci®c, easy to measure and can be detected at low concentrations. They are, therefore, commonly used to distinguish between smokers and nonsmokers since nicotine and cotinine levels are about 200 times greater in smokers and there is little overlap in the distributions of these markers. These biomarkers have also been used to distinguish between nonsmokers who are and who are not exposed to ETS. Three studies of nonsmoking adults, one from Japan (473 subjects), 58 an IARC multicentre study (1369 subjects) 16 and the health survey for England (6960 subjects), 59 have shown that the concentrations of serum and urinary cotinine increase signi®cantly with the number of cigarettes smoked by their spouse. Figure 4 shows the results from the health survey in England (1994) 59 ; cotinine levels are not zero in the unexposed group as some will be exposed to ETS outside the home. These studies con®rm that cotinine can be used to identify passive smokers and is sensitive to the extent of tobacco smoke exposure.
Although it has been suggested that nicotine can be obtained from sources other than tobacco, 61,62 for example tomatoes, it has been estimated that implausibly high quantities of these foods need to be consumed in order to achieve the concentrations of nicotine and cotinine observed in the body¯uids of passive smokers. 63 In smokers, there is a linear relationship between the risk of lung cancer and tobacco smoke intake up to about 25 cigarettes per day. 64 Since nicotine and cotinine are practically tobacco-speci®c and there is no evidence for a threshold for lung cancer at low-dose exposures, it is possible to compare levels of these markers in active smokers and nonsmokers exposed to ETS in order to obtain an indirect estimate of the risk of lung cancer. Table 4 shows the mean concentrations of nicotine and cotinine in the urine and saliva of nonsmokers who report exposure to ETS and in active smokers. In all studies, the mean concentrations in nonsmokers unexposed to ETS were lower than the concentrations in passive smokers (results not shown). When expressed as a percentage of the mean concentration in active smokers, passive smokers had about Table 4 Biochemical markers of tobacco smoke intake (nicotine and cotinine) in nonsmokers who are exposed to tobacco smoke and in smokers 1% of the concentration of that in active smokers which agrees with the conclusion reached by the United States EPA report. 10 From a linear extrapolation, it is expected that passive smokers have 1% of the risk of lung cancer in active smokers (relative risk 20 70, 71 ), that is an estimated relative risk of 1.19 (excess risk 19%) . This estimate is close to the one obtained directly from the epidemiological studies (24%, relative risk 1.24, Table 1 ).
Toxicological studies
There are several thousand chemicals and toxic agents in tobacco smoke. Environmental tobacco smoke consists mainly of sidestream smoke (90%), which is emitted from the burning end of the cigarette (the smoke inhaled by the smoker is called mainstream smoke) and it has been shown that concentrations of carcinogens such as polynuclear aromatic hydrocarbons, aromatic amines and nitrosamines are higher in sidestream smoke. For example, the concentration of benzo[a]pyrene (a polynuclear aromatic hydrocarbon and known respiratory carcinogen) is up to four times greater in sidestream smoke than in mainstream smoke; the concentration of another known carcinogen (of the bladder), 4-aminobiphenyl, is about 30 times greater. 72 Once breathed into the lungs, these carcinogens pass into the bloodstream and chemically bond with, for example, haemoglobin or DNA to form adducts. Measurements of these carcinogen adducts have been obtained in the blood and urine of smokers, 73 and there have been several studies in nonsmokers who report exposure to ETS. Table 5 shows the median (or mean) concentration of carcinogen adducts in nonsmokers who did and did not report exposure to environmental tobacco smoke. Although the studies were generally small, concentrations were greater in passive smokers. A valuable further study, 78 was one in which ®ve nonsmokers were purposely exposed to sidestream tobacco smoke for 3 h in a room with little ventilation and urine samples were collected before and after exposure. The study showed that urinary The mean in 31 smokers was 0.80 fmol/"g. c The median in 15 smokers was 143 pg/g Hb. concentrations of 4-(methylnitrosamino)-L-(3-pyridyl)-L-butanol (NNAL) (a metabolite of 4-(methylnitrosamino)-L-(3-pyridyl)-L-butanone (NNK) which is a tobacco-speci®c lung carcinogen), were statistically signi®cantly higher after exposure (p`0.001) and there was, on average, almost a 10-fold increase in NNAL concentrations.
These observations are consistent with the higher concentrations of carcinogens in ambient air which contain tobacco smoke 72 and they con®rm that carcinogens in ETS are indeed inhaled into the lungs and then passed into the blood and urine.
Discussion
Passive smoking is, beyond all reasonable doubt, a cause of lung cancer in nonsmokers as (1) it involves breathing in and metabolizing the same carcinogens that cause lung cancer in active smokers; (2) there is generally no threshold level of exposure to a carcinogen below which there is no increased risk; (3) epidemiological studies of nonsmoking women show a statistically signi®cant increased risk in those living with a smoker which increases with the extent of exposure; and (4) measures of tobacco smoke inhalation and known carcinogens are raised in passive smokers.
Much of the scienti®c evidence, the estimate of risk in particular, comes from the epidemiological studies. Whilst they differ in design and methodology, the important and sometimes overlooked consideration is that the results are statistically consistent with each other. Only six of 37 studies of nonsmoking women had relative risks below one ± all were statistically nonsigni®cant. In contrast, there were seven studies with raised relative risks which individually showed statistical signi®cance. Furthermore, the demonstration of a dose±response relationship between lung cancer risk and the amount of ETS exposure was useful additional evidence.
It is implausible that misclassi®cation bias can explain the entire excess risk due to passive smoking, as it would require unreasonably high magnitudes of the factors which determine the effect of this bias to make the risk estimate statistically nonsigni®cant. Diet can only be a confounder if it can be shown that certain dietary nutrients are causally related to lung cancer ± the scienti®c evidence on this issue is, at present, inconclusive. Assuming there was a causal relationship between diet and lung cancer, the difference in diet between nonsmokers who live with a smoker and those who do not is small and so the effect on the risk due to passive smoking is also small. Background exposure to ETS in studies of spousal smoking will dilute the risk and should, therefore, be allowed for in any analysis of such studies which use this marker as a measure of exposure. The overall effect of allowing for all three (bias, confounding and background exposure) is that they tend to cancel each other out.
The estimated excess risk of lung cancer attributable to passive smoking is, on average, about 26%, although the risk will be higher in heavily polluted environments. It may be argued that such a relatively small excess risk cannot be used as evidence for a causal relationship. This would perhaps be true on its own and if this were a new area of research. However, this is not the case for passive smoking because it is similar to active smoking and there is an enormous amount of scienti®c evidence on lung cancer in smokers. Passive smoking is, on average, perhaps equivalent to smoking one quarter to a half a cigarette a day. 79 There is, therefore, strong biological plausibility that passive smoking causes lung cancer. The magnitude of the excess risk is reasonable and consistent with the risk in active smokers, as evidenced by nicotine and cotinine studies.
The Health Survey of England 1994 59 of nearly 16 000 adults showed that one in every six nonsmokers were exposed to ETS in the home; the ®gure for total exposure is likely to be higher if allowance is also made for exposure outside the home. In nonsmokers, passive smoking would, therefore, be responsible for several hundred deaths from lung cancer each year in Britain. The United States EPA report 10 estimated that there are about 3000 deaths due to lung cancer in nonsmokers each year in the USA. Passive smoking, therefore, represents an important public health issue, particularly in light of the increasing amount of evidence of the effects on diseases other than lung cancer, such as heart disease and disorders in children. 80±83 Public health prevention strategies to encourage smokers not to smoke in the presence of nonsmokers at home, and to restrict smoking at work and in social settings, are required in order to reduce or eliminate the effect of this avoidable cause of mortality and morbidity amongst nonsmokers.
